LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma.

Front Oncol · 2020 · PMC7885862 · PMID 33604288

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

borderline significanceP = 0.055so close (0.05 < p ≤ 0.1)

We also found that LCN2 expression was an independent prognostic factor for LRFS, but with borderline significance ( P = 0.055).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.